Cargando…

Xeomin(®), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury

Xeomin(®) is a commercial formulation of botulinum neurotoxin type A (BoNT/A) clinically authorized for treating neurological disorders, such as blepharospasm, cervical dystonia, limb spasticity, and sialorrhea. We have previously demonstrated that spinal injection of laboratory purified 150 kDa BoN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastrorilli, Valentina, De Angelis, Federica, Vacca, Valentina, Pavone, Flaminia, Luvisetto, Siro, Marinelli, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142820/ https://www.ncbi.nlm.nih.gov/pubmed/37104185 http://dx.doi.org/10.3390/toxins15040248

Ejemplares similares

Botulinum Neurotoxin for Pain Management: Insights from Animal Models
por: Pavone, Flaminia, et al.
Publicado: (2010)

The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes
por: Marinelli, Sara, et al.
Publicado: (2012)

Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice
por: Vacca, Valentina, et al.
Publicado: (2020)

Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model
por: Finocchiaro, Alba, et al.
Publicado: (2018)

Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells
por: Luvisetto, Siro
Publicado: (2022)

Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012)

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
por: Luvisetto, Siro
Publicado: (2021)

17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice
por: Vacca, Valentina, et al.
Publicado: (2016)

Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications
por: Luvisetto, Siro
Publicado: (2020)

Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders
por: Luvisetto, Siro, et al.
Publicado: (2015)

Dataset of botulinum toxin A influence on interleukins under neuropathy
por: Zychowska, Magdalena, et al.
Publicado: (2016)

Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System
por: Luvisetto, Siro
Publicado: (2020)

Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait
por: Falso, Maurizio, et al.
Publicado: (2012)

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
por: Jimenez-Shahed, Joohi
Publicado: (2012)

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Publicado: (2018)

Introduction to the Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases
por: Luvisetto, Siro
Publicado: (2023)

Comparison of botulinum neurotoxin type A formulations in Asia
por: Frevert, Jürgen, et al.
Publicado: (2018)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN(®)) Botulinum Toxin in Chronic Refractory Migraine
por: Ion, Ioana, et al.
Publicado: (2018)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases
por: Marinelli, Sara, et al.
Publicado: (2019)

Publisher Correction: Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases
por: Marinelli, Sara, et al.
Publicado: (2019)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm
por: Park, Juwan, et al.
Publicado: (2011)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021)

Sex Differences in Neuropathy: The Paradigmatic Case of MetFormin
por: De Angelis, Federica, et al.
Publicado: (2022)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Tables of Toxicity of Botulinum and Tetanus Neurotoxins
por: Rossetto, Ornella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jd21er0hp99t68j3csbn870h49